Passalacqua, Luiz F. M. http://orcid.org/0000-0002-5490-2427
Starich, Mary R. http://orcid.org/0000-0002-8603-4628
Link, Katie A. http://orcid.org/0000-0001-7140-2005
Wu, Jiahui http://orcid.org/0000-0003-2406-6728
Knutson, Jay R.
Tjandra, Nico http://orcid.org/0000-0001-6365-5811
Jaffrey, Samie R. http://orcid.org/0000-0003-3615-6958
Ferré-D’Amaré, Adrian R. http://orcid.org/0000-0003-4549-1619
Funding for this research was provided by:
Intramural NHLBI funding.
Article History
Received: 12 December 2022
Accepted: 11 May 2023
First Online: 23 May 2023
Competing interests
: S.R.J. is the co-founder and has equity in Chimerna Therapeutics and Lucerna Technologies. Lucerna has licensed technology related to Spinach and other RNA-fluorophore complexes. All other authors declare no competing interest.